-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-1-integrase-inhibitor-9
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/2709085-95-8.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2709085-95-8 |
| Description | HIV-1 integrase inhibitor 9 (compound 8a) is a potent HIV-1 RNase H inhibitor with an IC50 of 12.3 μM. HIV-1 integrase inhibitor 9 shows an antiviral activity. |
Product Information
| Synonyms | HIV-1 integrase inhibitor 9|CHEMBL4867922|BDBM50579011|HY-132572|CS-0201133 |
| Molecular Weight | 416.3 |
| Molecular Formula | C18H12N2O10 |
| Canonical SMILES | COC(=O)C1=C(C=CC(=C1)NC(=O)C2=CC3=CC(=C(C(=C3OC2=O)O)O)[N+](=O)[O-])O |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 763 |
| Exact Mass | 416.04919458 |
| Target | HIV-1 RNase H:12.3 nM (IC50) |
| XLogP3-AA | 2.7 |